Table Of Contents
1 Table Of Contents 2
1.1 List of Tables 7
1.2 List of Figures 8
2 Executive Summary 10
2.1 Rapid Tests and Point of Care Market Forecast to Increase at a CAGR of 7% During the Period 2010–2017 10
2.2 Significant Consolidation in Recent Years to Reshape the Competitive Landscape in the Industry 11
2.3 Clinical Chemistry Rapid Tests and POC to Continue to be the Largest Segment in the Global Rapid Tests and Point of Care Market 11
3 Introduction 13
3.1 GBI Research Guidance 14
4 Global Rapid Tests and Point of Care Market: Market Characterization 15
4.1 Global Rapid Tests and Point of Care Market, Revenue ($m), 2003 – 2010 15
4.2 Global Rapid Tests and Point of Care Market, Revenue ($m), 2010 – 2017 16
4.3 Global Rapid Tests and Point of Care Market, Key Market Trends 17
4.3.1 Decentralization of Laboratories is a Growing Trend Across the World 17
4.3.2 Integration of POC Devices with Hospital Information Systems is a Growing Trend 18
4.3.3 Significant Consolidation in Recent Years to Reshape the Competitive Landscape of the Industry 18
4.3.4 Increased Demand for Rapid Tests and POC Testing in Emerging Countries Will Drive the Growth of the Market in the Near Future 19
4.4 Global Rapid Tests and Point of Care, Market Dynamics 20
4.4.1 Global Rapid Tests and Point of Care, Market Drivers 20
4.4.1.1 Continuing Improvements in Rapid Tests and POC Testing to Drive Market Growth 20
4.4.1.2 Advantages of Rapid Tests and POC Testing Over Traditional Laboratory Testing are Driving Market Growth 21
4.4.1.3 Expanded Menu of Point of Care Tests Will Result in Increased Usage of POC Testing, Leading to the Growth of the POC Tests and Rapid Tests Market 22
4.4.1.4 Increasing Prevalence of Infectious Diseases to Drive the Rapid Tests and POC Market Globally 22
4.4.2 Global Rapid Tests and Point of Care, Market Restraints 23
4.4.2.1 Pricing Pressures to Adversely Affect the Revenues of the Rapid Test and POC Test Industry 23
4.4.2.2 High Per Test Cost of Rapid Tests and POC Tests to Hinder Market Growth 23
4.4.2.3 Drawbacks Associated with POC Devices to Hinder Adoption Significantly 24
4.4.2.4 Complexity of Data Management and Error Management to Hinder Market Growth 24
5 Global Rapid Tests and Point of Care Market: Market Category Analysis and Forecasts 26
5.1 Clinical Chemistry Rapid Tests and POC 26
5.1.1 Clinical Chemistry Rapid Tests and POC Market, Global, Revenue ($m), 2003–2010 26
5.1.2 Clinical Chemistry Rapid Tests and POC Market, Global, Revenue Forecasts ($m), 2010–2017 27
5.2 Clinical Chemistry Rapid Tests and POC Market: Market Dynamics 28
5.2.1 Clinical Chemistry Rapid Tests and POC Market: Market Drivers 29
5.2.1.1 Increase in Percentage of Population Seeking Critical Care Will Drive the Clinical Chemistry Rapid Tests and POC Tests Market 29
5.2.1.2 Technological Advancements to Drive the Clinical Chemistry Rapid Tests and POC Tests Market 29
5.2.2 Clinical Chemistry Rapid Tests and POC Market: Market Restraints 30
5.2.2.1 Poor Sensitivity and Poor Specificity of Test Strips for Some Analytes to Slow Down Market Growth 30
5.3 Immunochemistry Rapid Tests Market 30
5.3.1 Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2003 – 2010 30
5.3.2 Immunochemistry Rapid Tests Market, Global, Revenue Forecasts ($m), 2010 – 2017 31
5.4 Immunochemistry Rapid Tests Market: Market Dynamics 32
5.4.1 Immunochemistry Rapid Tests Market: Market Drivers 32
5.4.1.1 Lateral Flow Assays to Drive the Immunochemistry Rapid Tests Market 33
5.4.1.2 Technological Advancements Such as Microfluidics in Rapid Immunoassays to Drive Market Growth 33
5.4.1.3 Wide Range of Immunoassay Applications to Drive the Immunochemistry Rapid Tests Market 34
5.4.2 Immunochemistry Rapid Tests Market: Market Restraints 34
5.4.2.1 Limitations Such as Low Sensitivity of Immuno Assays to Hinder Market Growth 34
5.5 Hematology Rapid Tests Market 35
5.5.1 Hematology Rapid Tests Market, Global, Revenue ($m), 2003 – 2010 35
5.5.2 Hematology Rapid Tests Market, Global, Revenue Forecasts ($m), 2010 – 2017 37
5.6 Hematology Rapid Tests Market: Market Dynamics 38
5.6.1 Hematology Rapid Tests Market: Market Drivers 38
5.6.1.1 Availability of Innovative Rapid Test Devices to Drive Market Growth 38
5.6.1.2 Blood Spot Tests to Drive the Growth of the Hematology Rapid Tests Market 38
5.6.2 Hematology Rapid Tests Market: Market Restraints 39
5.6.2.1 Limitations Such as Low Target Sensitivity and Small Volume of Dried Blood Spots to Slow Down Adoption Rates in the Near Future 39
6 Global Rapid Tests and Point of Care Market: Country Analysis and Forecasts 41
6.1 Rapid Tests and Point of Care Market: Cross–Country Analysis 41
6.2 Revenue Forecasts, by Country, 2003 – 2017 42
6.2.1 Rapid Tests and Point of Care Market, the US, Revenue ($m), 2003 – 2010 42
6.2.2 Rapid Tests and Point of Care Market, the US, Revenue ($m), 2010 – 2017 44
6.2.3 Rapid Tests and Point of Care Market, Canada, Revenue ($m), 2003 – 2010 45
6.2.4 Rapid Tests and Point of Care Market, Canada, Revenue ($m), 2010 – 2017 46
6.2.5 Rapid Tests and Point of Care Market, the UK, Revenue ($m), 2003 – 2010 47
6.2.6 Rapid Tests and Point of Care Market, the UK, Revenue ($m), 2010 – 2017 48
6.2.7 Rapid Tests and Point of Care Market, Germany, Revenue ($m), 2003–2010 50
6.2.8 Rapid Tests and Point of Care Market, Germany, Revenue ($m), 2010–2017 51
6.2.9 Rapid Tests and Point of Care Market, France, Revenue ($m), 2003–2010 52
6.2.10 Rapid Tests and Point of Care Market, France, Revenue ($m), 2010–2017 53
6.2.11 Rapid Tests and Point of Care Market, Italy, Revenue ($m), 2003–2010 54
6.2.12 Rapid Tests and Point of Care Market, Italy, Revenue ($m), 2010–2017 55
6.2.13 Rapid Tests and Point of Care Market, Spain, Revenue ($m), 2003–2010 56
6.2.14 Rapid Tests and Point of Care Market, Spain, Revenue ($m), 2010–2017 57
6.2.15 Rapid Tests and Point of Care Market, Japan, Revenue ($m), 2003–2010 58
6.2.16 Rapid Tests and Point of Care Market, Japan, Revenue ($m), 2010–2017 60
6.2.17 Rapid Tests and Point of Care Market, China, Revenue ($m), 2003–2010 61
6.2.18 Rapid Tests and Point of Care Market, China, Revenue ($m), 2010–2017 62
6.2.19 Rapid Tests and Point of Care Market, India, Revenue ($m), 2003–2010 63
6.2.20 Rapid Tests and Point of Care Market, India, Revenue ($m), 2010–2017 64
6.2.21 Rapid Tests and Point of Care Market, Australia, Revenue ($m), 2003–2010 66
6.2.22 Rapid Tests and Point of Care Market, Australia, Revenue ($m), 2010–2017 67
6.2.23 Rapid Tests and Point of Care Market, Brazil, Revenue ($m), 2003–2010 68
6.2.24 Rapid Tests and Point of Care Market, Brazil, Revenue ($m), 2010–2017 69
7 Global Rapid Tests and Point of Care Market: Key Market Participants 71
7.1 F. Hoffmann–La Roche Ltd. 71
7.1.1 Business Overview 71
7.1.2 Marketed Products 71
7.2 Abbott Laboratories 71
7.2.1 Business Overview 71
7.2.2 Marketed products 72
7.3 Siemens Healthcare (Subsidiary of Siemens AG) 72
7.3.1 Business Overview 73
7.3.2 Marketed Products 73
7.4 Beckman Coulter, Inc. (Subsidiary of Danaher Corporation) 73
7.4.1 Business Overview 73
7.4.2 Marketed Products: 74
7.5 bioMerieux S.A. (Subsidiary of Merieux Alliance Group) 74
7.5.1 Business Overview 75
7.5.2 Marketed products 75
7.6 DiaSorin S.p.A 75
7.6.1 Business Overview 75
7.6.2 Marketed Products: 76
8 Global Rapid Tests and Point of Care Market: Product Pipeline Analysis 77
8.1 Rapid Tests and Point of Care Market: Pipeline Product Summary 77
8.2 Rapid Tests and Point of Care Market: List of Pipeline Products 79
8.3 Rapid Tests and Point of Care: Profiles of Key Pipeline Products 81
8.3.1 ImmProCon Technology 81
8.3.2 RAPIDPoint 500 System – Lactate Assay 81
8.3.3 Sali–Chek Reader 82
8.3.4 Point Of Care Diagnostic Device 82
8.3.5 ACE Alera Clinical Chemistry System – Direct A1c Assay 83
8.3.6 Advia 120 Hematology System – IRF Test 83
8.3.7 AIA–600 II – D–dimer Test 84
9 Global Rapid Tests and Point of Care Market: Consolidation Landscape 86
9.1 Rapid Tests and Point of Care Market: Key Deals 2011 86
9.1.1 Sony Corporation of America Acquires Micronics 86
9.1.2 Roche Completes Acquisition of MTM Laboratories 86
9.1.3 Quest Diagnostics Completes Acquisition of Athena Diagnostics 86
9.1.4 Danaher Completes Acquisition of Beckman Coulter 87
9.2 Rapid Tests and Point of Care Market: Key Deals, 2007–2010 87
9.2.1 Merck Completes Acquisition of Millipore 87
9.2.2 Inverness Medical Innovations Acquires 78.13% Stake in Standard Diagnostics 88
9.2.3 Inverness Medical Innovations Completes Acquisition of Concateno from Marwyn 88
9.2.4 bioMerieux Acquires AviaraDx 89
9.2.5 Siemens Medical Acquires Dade Behring 89
9.2.6 Roche Acquires Ventana Medical Systems 89
9.2.7 Bio–Rad Laboratories Acquires Diamed 90
10 Appendix 91
10.1 Definitions 91
10.1.1 Clinical Chemistry Rapid Tests & POC 91
10.1.2 Immunochemistry Rapid Tests Market 91
10.1.3 Haematology Rapid Tests Market 91
10.2 Sources 91
10.3 Acronyms 92
10.4 Research Methodology 92
10.4.1 Secondary Research 92
10.4.2 Primary Research 93
10.4.3 Models 93
10.4.4 Forecasts 94
10.4.5 Expert Panels 94
10.5 Contact Us 94
10.6 Disclaimer 94
List of Tables
Table 1: Rapid Tests and Point of Care Market, Global, Revenue ($m), 2003–2010 15
Table 2: Rapid Tests and Point of Care Market, Global, Revenue ($m), 2010–2017 17
Table 3: Clinical Chemistry Rapid Tests and POC Market, Global, Revenue ($m), 2003–2010 27
Table 4: Clinical Chemistry Rapid Tests and POC Market, Global, Revenue ($m), 2010–2017 28
Table 5: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2003–2010 31
Table 6: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2010–2017 32
Table 7: Hematology Rapid Tests Market, Global, Revenue ($m), 2003–2010 36
Table 8: Hematology Rapid Tests Market, Global, Revenue ($m), 2010–2017 37
Table 9: Rapid Tests and Point of Care Market, Global, Cross Country Analysis, CAGR (%), 2003–2017 42
Table 10: Rapid Tests and Point of Care Market, the US, Revenue ($m), 2003–2010 43
Table 11: Rapid Tests and Point of Care Market, the US, Revenue ($m), 2010–2017 44
Table 12: Rapid Tests and Point of Care Market, Canada, Revenue ($m), 2003–2010 46
Table 13: Rapid Tests and Point of Care Market, Canada, Revenue ($m), 2010–2017 47
Table 14: Rapid Tests and Point of Care Market, the UK, Revenue ($m), 2003–2010 48
Table 15: Rapid Tests and Point of Care Market, the UK, Revenue ($m), 2010–2017 49
Table 16: Rapid Tests and Point of Care Market, Germany, Revenue ($m), 2003–2010 50
Table 17: Rapid Tests and Point of Care Market, the Germany, Revenue ($m), 2010–2017 51
Table 18: Rapid Tests and Point of Care Market, France, Revenue ($m), 2003–2010 52
Table 19: Rapid Tests and Point of Care Market, France, Revenue ($m), 2010–2017 53
Table 20: Rapid Tests and Point of Care Market, Italy, Revenue ($m), 2003–2010 55
Table 21: Rapid Tests and Point of Care Market, Italy, Revenue ($m), 2010–2017 56
Table 22: Rapid Tests and Point of Care Market, Spain, Revenue ($m), 2003–2010 57
Table 23: Rapid Tests and Point of Care Market, Spain, Revenue ($m), 2010–2017 58
Table 24: Rapid Tests and Point of Care Market, Japan, Revenue ($m), 2003–2010 59
Table 25: Rapid Tests and Point of Care Market, Japan, Revenue ($m), 2010–2017 60
Table 26: Rapid Tests and Point of Care Market, China, Revenue ($m), 2003–2010 61
Table 27: Rapid Tests and Point of Care Market, China, Revenue ($m), 2010–2017 63
Table 28: Rapid Tests and Point of Care Market, India, Revenue ($m), 2003–2010 64
Table 29: Rapid Tests and Point of Care Market, India, Revenue ($m), 2010–2017 65
Table 30: Rapid Tests and Point of Care Market, Australia, Revenue ($m), 2003–2010 66
Table 31: Rapid Tests and Point of Care Market, Australia, Revenue ($m), 2010–2017 67
Table 32: Rapid Tests and Point of Care Market, Brazil, Revenue ($m), 2003-2010 68
Table 33: Rapid Tests and Point of Care Market, Brazil, Revenue ($m), 2010–2017 70
Table 34: Rapid Tests and Point of Care Market, Global, Pipeline Product Summary, 2010 77
Table 35: Rapid Tests and Point of Care Market, Pipeline Assessment, by Development Stage 78
Table 36: Rapid Tests and Point of Care Market, Global, List of Pipeline Products, 2010–11 80
Table 37: Rapid Tests and Point of Care Market, Global, List of Pipeline Products, 2010–12 81
Table 38: ImmProCon Technology, Product Status, 2011 81
Table 39: RAPIDPoint 500 System, Product Status, 2011 82
Table 40: Sali–Chek Reader, Product Status, 2011 82
Table 41: Point Of Care Diagnostic Device, Product Status, 2011 83
Table 42: ACE Alera Clinical Chemistry System – Direct A1c Assay, Product Status, 2011 83
Table 43: Advia 120 Hematology System – IRF (Immature Reticulocyte Fraction) Test, Product Status, 2011 84
Table 44: Advia 2120 Hematology System – MPC (Mean Platelet Component) Test, Product Status, 2011 84
Table 45: AIA (Automated Immunoassay Analyzer)–600 II – D–dimer Test, Product Status, 2011 85
List of Figures
Figure 1: Rapid Tests and Point of Care Market, Global, Revenue ($bn), 2010–2017 10
Figure 2: Clinical Chemistry Rapid Tests and POC, Global, Segment–Wise Revenue, ($m), 2010 12
Figure 3: Rapid Tests and Point of Care Market, Global, Revenue ($m), 2003–2010 15
Figure 4: Rapid Tests and Point of Care Market, Global, Revenue ($m), 2010–2017 16
Figure 5: Rapid Tests and Point of Care Market, Market Categorization and Segmentation 26
Figure 6: Clinical Chemistry Rapid Tests and POC Market, Global, Revenue ($m), 2003–2010 27
Figure 7: Clinical Chemistry Rapid Tests and POC Market, Global, Revenue ($m), 2010–2017 28
Figure 8: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2003–2010 31
Figure 9: Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2010–2017 32
Figure 10: Hematology Rapid Tests Market, Global, Revenue ($m), 2003–2010 36
Figure 11: Hematology Rapid Tests Market, Global, Revenue ($m), 2010–2017 37
Figure 12: Tests and Point of Care Market, Global, Cross Country Analysis, CAGR (%), 2003–2017 41
Figure 13: Tests and Point of Care Market, the US, Revenue ($m), 2003–2010 43
Figure 14: Rapid Tests and Point of Care Market, the US, Revenue ($m), 2010–2017 44
Figure 15: Rapid Tests and Point of Care Market, Canada, Revenue ($m), 2003–2010 45
Figure 16: Rapid Tests and Point of Care Market, Canada, Revenue ($m), 2010–2017 47
Figure 17: Rapid Tests and Point of Care Market, the UK, Revenue ($m), 2003–2010 48
Figure 18: Rapid Tests and Point of Care Market, the UK, Revenue ($m), 2010–2017 49
Figure 19: Rapid Tests and Point of Care Market, Germany, Revenue ($m), 2003–2010 50
Figure 20: Rapid Tests and Point of Care Market, Germany, Revenue ($m), 2010–2017 51
Figure 21: Rapid Tests and Point of Care Market, France, Revenue ($m), 2003–2010 52
Figure 22: Rapid Tests and Point of Care Market, France, Revenue ($m), 2010–2017 53
Figure 23: Rapid Tests and Point of Care Market, Italy, Revenue ($m), 2003–2010 54
Figure 24: Rapid Tests and Point of Care Market, Italy, Revenue ($m), 2010–2017 56
Figure 25: Rapid Tests and Point of Care Market, Spain, Revenue ($m), 2003–2010 57
Figure 26: Rapid Tests and Point of Care Market, Spain, Revenue ($m), 2010–2017 58
Figure 27: Tests and Point of Care Market, Japan, Revenue ($m), 2003–2010 59
Figure 28: Tests and Point of Care Market, Japan, Revenue ($m), 2010–2017 60
Figure 29: Rapid Tests and Point of Care Market, China, Revenue ($m), 2003–2010 61
Figure 30: Rapid Tests and Point of Care Market, China, Revenue ($m), 2010–2017 62
Figure 31: Rapid Tests and Point of Care Market, India, Revenue ($m), 2003–2010 64
Figure 32: Rapid Tests and Point of Care Market, India, Revenue ($m), 2010–2017 65
Figure 33: Rapid Tests and Point of Care Market, Australia, Revenue ($m), 2003–2010 66
Figure 34: Rapid Tests and Point of Care Market, Australia, Revenue ($m), 2010–2017 67
Figure 35: Rapid Tests and Point of Care Market, Brazil, Revenue ($m), 2003-2010 68
Figure 36: Rapid Tests and Point of Care Market, Brazil, Revenue ($m), 2010–2017 69
Figure 37: Rapid Tests and Point of Care Market, Global, Pipeline Product Summary (%), 2010 77
Figure 38: Rapid Tests and Point of Care Market, Pipeline Assessment, by Development Stage 78